Europe’s Hidden Strategic Asset: Affordable Medicines


9:00 am - 10:30 am
Europe’s Hidden Strategic Asset: Affordable Medicines

Wednesday, 02. September
Content
90 minutes
English

What does it take to build a stronger, more resilient Europe? Secure access to affordable medicines made in Europe is emerging as a cornerstone of economic competitiveness, critical infrastructure resilience, and defense readiness. Marking 20 years of biosimilars in Europe, this session brings together leaders from health, industry, and policy and explores how Europe can transform resilience into a strategic advantage and strengthen its capacity to thrive in an uncertain world. 

Supported by Sandoz
speaker-image
Speaker

Korinna Schumann

Federal Minister Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection (BMASGPK)
speaker-image
Speaker

Herwig Ostermann

Executive Director Austrian National Public Health Institute (GÖG)